Dr. Koo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2611 West End Ave Suite 210
Nashville, TN 37203
Summary
- Dr. Grace Koo is an academic allergist/immunologist at Vanderbilt University Medical Center in Nashville, TN. She sees both adult and pediatric patients. She is the Director of Education for Residents and Medical Students for the section of Allergy/Immunology. She is also a drug allergy clinical researcher, investigating delabeling of drug allergy labels and its impact.
Education & Training
- Vanderbilt University Medical CenterFellowship, Allergy and Immunology, 2020 - 2022
- Loyola Medicine MacNeal HospitalChief Residency, Internal Medicine, 2019 - 2020
- University of ChicagoResidency, Internal Medicine, 2016 - 2019
- University of Maryland School of MedicineClass of 2016
Certifications & Licensure
- TN State Medical License 2022 - 2025
- IL State Medical License 2016 - 2020
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Impacts of risk-stratified inpatient penicillin allergy label delabeling on subsequent antimicrobial spectrum index and costs.Milner Staub, George E Nelson, Kelly Byrge, Grace Koo, Whitney J Nesbitt
Antimicrobial Stewardship & Healthcare Epidemiology. 2024-01-01 - Building the Evidence Base for Safe Direct Cephalosporin Challenges.Allison E Norton, Grace Koo, Cosby A Stone Jr
The Journal of Allergy and Clinical Immunology. in Practice. 2024-01-01 - 5 citationsRisk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit.Joanna L Stollings, Grace Koo, Christopher J Lindsell, Mary Lynn Dear, Allison McCoy
The Journal of Allergy and Clinical Immunology. in Practice. 2023-02-01
Press Mentions
- ICU Study Confirms Safety of Delabeling Penicillin AllergiesMarch 10th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: